Annexin A2also known asannexin IIis aproteinthat in humans is encoded by theANXA2gene.[5]

ANXA2
Available structures
PDBOrtholog search:PDBeRCSB
Identifiers
AliasesANXA2,ANX2, ANX2L4, CAL1H, HEL-S-270, LIP2, LPC2, LPC2D, P36, PAP-IV, annexin A2
External IDsOMIM:151740;MGI:88246;HomoloGene:20857;GeneCards:ANXA2;OMA:ANXA2 - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001002857
NM_001002858
NM_001136015
NM_004039

NM_007585

RefSeq (protein)

NP_001002857
NP_001002858
NP_001129487
NP_004030

NP_031611

Location (UCSC)Chr 15: 60.35 – 60.4 MbChr 9: 69.36 – 69.4 Mb
PubMedsearch[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Annexin 2 is involved in diverse cellular processes such ascell motility(especially that of theepithelial cells), linkage of membrane-associated protein complexes to the actincytoskeleton,endocytosis,fibrinolysis,ion channelformation, andcell matrixinteractions. It is a calcium-dependent phospholipid-binding protein whose function is to help organizeexocytosisof intracellular proteins to the extracellular domain. Annexin II is apleiotropicprotein meaning that its function is dependent on place and time in the body.

Gene

edit

TheANXA2gene, located at 15q22.2, has threepseudogeneslocated on chromosomes 4, 9 and 10, respectively. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene.[6]

Function

edit

This protein is a member of theannexinfamily. Members of this calcium-dependent phospholipid-binding protein family play a role in the regulation of cellular growth and in signal transduction pathways. This protein functions as an autocrine factor which heightens osteoclast formation and bone resorption.[6]Epigenetic regulation of Annexin A2 has been identified as a key determinant of mesenchymal transformation in brain tumors.[7]Maternal deficiency of the ANXA2 gene contributes to shallow decidual invasion by placental cytotrophoblast cells. These findings highlight the maternal contribution to the pathogenesis of severepreeclampsia.[8]

Annexin A2 has been proposed to function inside the cell in sorting ofendosomesand outside the cell inanticoagulantreactions.

Interactions

edit

Annexin A2 has been shown tointeractwithProhibitin,[9]CEACAM1,[10]S100A10,[11][12]PCNA,[13]complementFactor H,[14]and a number of viral factors including theHPV16minorcapsid protein L2.[15][16]

See also

edit

References

edit
  1. ^abcGRCh38: Ensembl release 89: ENSG00000182718Ensembl,May 2017
  2. ^abcGRCm38: Ensembl release 89: ENSMUSG00000032231Ensembl,May 2017
  3. ^"Human PubMed Reference:".National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^"Mouse PubMed Reference:".National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^Takahashi S, Reddy SV, Chirgwin JM, Devlin R, Haipek C, Anderson J, Roodman GD (November 1994)."Cloning and identification of annexin II as an autocrine/paracrine factor that increases osteoclast formation and bone resorption".The Journal of Biological Chemistry.269(46): 28696–28701.doi:10.1016/S0021-9258(19)61961-7.PMID7961821.
  6. ^ab"Entrez Gene: ANXA2 annexin A2".
  7. ^Kling T, Ferrarese R, Ó hAilín D, Johansson P, Heiland DH, Dai F, et al. (October 2016)."Integrative Modeling Reveals Annexin A2-mediated Epigenetic Control of Mesenchymal Glioblastoma".eBioMedicine.12:72–85.doi:10.1016/j.ebiom.2016.08.050.PMC5078587.PMID27667176.
  8. ^Ng SW, Norwitz GA, Pavlicev M, Tilburgs T, Simón C, Norwitz ER (June 2020)."Endometrial Decidualization: The Primary Driver of Pregnancy Health".International Journal of Molecular Sciences.21(11): 4092.doi:10.3390/ijms21114092.PMC7312091.PMID32521725.
  9. ^Bacher S, Achatz G, Schmitz ML, Lamers MC (December 2002). "Prohibitin and prohibitone are contained in high-molecular weight complexes and interact with alpha-actinin and annexin A2".Biochimie.84(12): 1207–1220.doi:10.1016/S0300-9084(02)00027-5.PMID12628297.
  10. ^Kirshner J, Schumann D, Shively JE (December 2003)."CEACAM1, a cell-cell adhesion molecule, directly associates with annexin II in a three-dimensional model of mammary morphogenesis".The Journal of Biological Chemistry.278(50): 50338–50345.doi:10.1074/jbc.M309115200.PMID14522961.
  11. ^Réty S, Sopkova J, Renouard M, Osterloh D, Gerke V, Tabaries S, et al. (January 1999). "The crystal structure of a complex of p11 with the annexin II N-terminal peptide".Nature Structural Biology.6(1): 89–95.doi:10.1038/4965.PMID9886297.S2CID26400923.
  12. ^He KL, Deora AB, Xiong H, Ling Q, Weksler BB, Niesvizky R, Hajjar KA (July 2008)."Endothelial cell annexin A2 regulates polyubiquitination and degradation of its binding partner S100A10/p11".The Journal of Biological Chemistry.283(28): 19192–19200.doi:10.1074/jbc.M800100200.PMC2443646.PMID18434302.
  13. ^Ohta S, Shiomi Y, Sugimoto K, Obuse C, Tsurimoto T (October 2002)."A proteomics approach to identify proliferating cell nuclear antigen (PCNA)-binding proteins in human cell lysates. Identification of the human CHL12/RFCs2-5 complex as a novel PCNA-binding protein".The Journal of Biological Chemistry.277(43): 40362–40367.doi:10.1074/jbc.M206194200.PMID12171929.
  14. ^Leffler J, Herbert AP, Norström E, Schmidt CQ, Barlow PN, Blom AM, Martin M (February 2010)."Annexin-II, DNA, and histones serve as factor H ligands on the surface of apoptotic cells".The Journal of Biological Chemistry.285(6): 3766–3776.doi:10.1074/jbc.M109.045427.PMC2823518.PMID19951950.
  15. ^Woodham AW, Da Silva DM, Skeate JG, Raff AB, Ambroso MR, Brand HE, et al. (2012)."The S100A10 subunit of the annexin A2 heterotetramer facilitates L2-mediated human papillomavirus infection".PLOS ONE.7(8): e43519.Bibcode:2012PLoSO...743519W.doi:10.1371/journal.pone.0043519.PMC3425544.PMID22927980.
  16. ^Woodham AW, Raff AB, Raff LM, Da Silva DM, Yan L, Skeate JG, et al. (May 2014)."Inhibition of Langerhans cell maturation by human papillomavirus type 16: a novel role for the annexin A2 heterotetramer in immune suppression".Journal of Immunology.192(10): 4748–4757.doi:10.4049/jimmunol.1303190.PMC4019435.PMID24719459.

Further reading

edit
edit